Cargando…
Insulin/Glucose-Responsive Cells Derived from Induced Pluripotent Stem Cells: Disease Modeling and Treatment of Diabetes
Type 2 diabetes, characterized by dysfunction of pancreatic β-cells and insulin resistance in peripheral organs, accounts for more than 90% of all diabetes. Despite current developments of new drugs and strategies to prevent/treat diabetes, there is no ideal therapy targeting all aspects of the dise...
Autores principales: | Gheibi, Sevda, Singh, Tania, da Cunha, Joao Paulo M. C. M., Fex, Malin, Mulder, Hindrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696367/ https://www.ncbi.nlm.nih.gov/pubmed/33198288 http://dx.doi.org/10.3390/cells9112465 |
Ejemplares similares
-
Ribosomal biogenesis regulator DIMT1 controls β-cell protein synthesis, mitochondrial function, and insulin secretion
por: Verma, Gaurav, et al.
Publicado: (2022) -
The human batokine EPDR1 regulates β-cell metabolism and function
por: Cataldo, Luis Rodrigo, et al.
Publicado: (2022) -
EndoC-βH5 cells are storable and ready-to-use human pancreatic beta cells with physiological insulin secretion
por: Blanchi, Bruno, et al.
Publicado: (2023) -
Insulin secretion: The nitric oxide controversy
por: Gheibi, Sevda, et al.
Publicado: (2020) -
Mitochondrial transcription factor B2 is essential for mitochondrial and cellular function in pancreatic β-cells
por: Nicholas, Lisa M., et al.
Publicado: (2017)